Drug Type Small molecule drug |
Synonyms (E)-4-[3'-(1-Adamantyl)-4'-hydroxyphenyl]-3-chlorocinnamic acid, 3-Cl-AHPC |
Target |
Mechanism Orphan nuclear receptor modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H25ClO3 |
InChIKeyZUIMAMHUQKPCBR-QHHAFSJGSA-N |
CAS Registry524937-17-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | US | 06 May 2011 |